Typhoid Fever - Pipeline Review, H2 2016 - Global Markets Direct - Market Research

Typhoid Fever - Pipeline Review, H2 2016

Typhoid Fever - Pipeline Review, H2 2016 - Global Markets Direct - Market Research
Typhoid Fever - Pipeline Review, H2 2016
Published Jul 20, 2016
55 pages — Published Jul 20, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Typhoid Fever - Pipeline Review, H2 2016, provides an overview of the Typhoid Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Typhoid Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Typhoid Fever
- The report reviews pipeline therapeutics for Typhoid Fever by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Typhoid Fever therapeutics and enlists all their major and minor projects
- The report assesses Typhoid Fever therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Typhoid Fever

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Typhoid Fever
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Typhoid Fever pipeline depth and focus of Indication therapeutics
- Develop and design in

  
Source:
Document ID
GMDHC8239IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables51
  List of Figures51
Introduction61
  Global Markets Direct Report Coverage61
Typhoid Fever Overview71
Therapeutics Development82
  Pipeline Products for Typhoid Fever Overview81
  Pipeline Products for Typhoid Fever Comparative Analysis91
Typhoid Fever Therapeutics under Development by Companies101
Typhoid Fever Therapeutics under Investigation by Universities/Institutes111
Typhoid Fever Pipeline Products Glance124
  Late Stage Products121
  Clinical Stage Products131
  Early Stage Products141
  Unknown Stage Products151
Typhoid Fever Products under Development by Companies161
Typhoid Fever Products under Investigation by Universities/Institutes171
Typhoid Fever Companies Involved in Therapeutics Development189
  GlaxoSmithKline Plc181
  Indian Immunologicals Limited191
  Nanotherapeutics, Inc.201
  Prokarium Limited211
  Protein Potential, LLC221
  Sanofi Pasteur SA231
  Shantha Biotechnics Limited241
  SK Chemicals Co., Ltd.251
  Zydus Cadila Healthcare Limited261
Typhoid Fever Therapeutics Assessment278
  Assessment by Monotherapy Products271
  Assessment by Combination Products281
  Assessment by Target292
  Assessment by Route of Administration312
  Assessment by Molecule Type332
Drug Profiles3513
  (paratyphoid (bivalent) + typhoid) vaccine Drug Profile351
  (paratyphoid + typhoid) vaccine Drug Profile361
  (shigella + typhoid) vaccine Drug Profile371
  (Streptococcal pneumonia + typhoid) vaccine Drug Profile381
  Typhella Drug Profile392
  Typhetec Drug Profile411
  typhoid vaccine Drug Profile421
  typhoid vaccine Drug Profile431
  typhoid vaccine Drug Profile441
  typhoid vaccine Drug Profile451
  typhoid Vi polysaccharide [strain S typhi Ty2] vaccine Drug Profile461
  ViCRM-197 Drug Profile471
Typhoid Fever Dormant Projects481
Typhoid Fever Discontinued Products491
Typhoid Fever Product Development Milestones504
  Featured News &Press Releases501
    Mar 11, 2013: Prokarium And University Of Birmingham Receive 0.4m Grant To Develop Next Generation Vaccines501
    Oct 05, 2012: Sanofi Pasteur Voluntarily Recalls Few Batches Of Typhoid Fever Vaccine501
    Jun 23, 2011: Sanofi Pasteur s Typhim Vi Receives Prequalification From World Health Organization501
    Jun 05, 2008: Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate511
    Jan 08, 2008: Emergent BioSolutions Announces Final Phase II Clinical Study Results for Typhoid Vaccine511
    Nov 21, 2005: Emergent Biosolutions Starts Clinical Study Of Single-Dose Oral Typhoid Vaccine521
    Aug 30, 2005: Emergent Biosolutions' Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study521
    Nov 29, 1994: Food And Drug Administration Grants License For A New Typhoid Fever Vaccine531
Appendix542
  Methodology541
  Coverage541
  Secondary Research541
  Primary Research541
  Expert Panel Validation541
  Contact Us541
  Disclaimer551

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Typhoid Fever - Pipeline Review, H2 2016" Jul 20, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Typhoid-Fever-Pipeline-Review-H2-2016-2088-16213>
  
APA:
Global Markets Direct - Market Research. (2016). Typhoid Fever - Pipeline Review, H2 2016 Jul 20, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Typhoid-Fever-Pipeline-Review-H2-2016-2088-16213>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.